# Vallon Pharmaceuticals Inc. (VLON) Source: https://www.quantisnow.com/company/VLON Generated: 2026-11-10T21:27:48.174Z - Ticker: VLON - Exchange: NASDAQ - Sector: Health Care - Industry: Medicinal Chemicals and Botanical Products - IPO year: 2021 - Website: vallon-pharma.com ## About Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of prescription drugs for central nervous system disorders. The company develops abuse-deterrent amphetamine immediate-release, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder and narcolepsy. It also develops ADMIR, an abuse deterrent formulation of Ritalin. Vallon Pharmaceuticals, Inc. was incorporated in 2018 and is based in Philadelphia, Pennsylvania. ## Latest VLON news and filings - 2024-02-02 21:25 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Vallon Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-vallon-pharmaceuticals-inc-5226839) - 2024-02-02 21:23 UTC [SEC Form 8-K] [Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/vallon-pharmaceuticals-inc-filed-sec-form-8-k-entry-into-a-5226815) - 2024-02-02 21:21 UTC [SEC Form 424B4 filed by Vallon Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-424b4-filed-by-vallon-pharmaceuticals-inc-5226798) - 2024-02-02 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Vallon Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-vallon-pharmaceuticals-inc-5224837) - 2024-01-31 21:24 UTC [SEC Form S-1] [SEC Form S-1/A filed by Vallon Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-s-1a-filed-by-vallon-pharmaceuticals-inc-amendment-5220696) - 2024-01-31 02:34 UTC [SEC Form S-1] [SEC Form S-1/A filed by Vallon Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-s-1a-filed-by-vallon-pharmaceuticals-inc-amendment-5218509) - 2024-01-30 13:13 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Vallon Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-vallon-pharmaceuticals-inc-5215951) - 2024-01-30 13:12 UTC [SEC Form 8-K] [Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/vallon-pharmaceuticals-inc-filed-sec-form-8-k-material-modification-to-5215950) - 2024-01-19 21:16 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Vallon Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-vallon-pharmaceuticals-inc-5196477) - 2024-01-19 21:15 UTC [SEC Form 8-K] [Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/vallon-pharmaceuticals-inc-filed-sec-form-8-k-submission-of-matters-5196453) - 2024-01-16 13:45 UTC [SEC Form 8-K] [Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/vallon-pharmaceuticals-inc-filed-sec-form-8-k-regulation-fd-disclosure-5187741) - 2024-01-06 00:06 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Vallon Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-vallon-pharmaceuticals-inc-5174260) - 2024-01-06 00:05 UTC [SEC Form 8-K] [Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/vallon-pharmaceuticals-inc-filed-sec-form-8-k-notice-of-delisting-5174259) - 2024-01-06 00:07 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Vallon Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-vallon-pharmaceuticals-inc-5174254) - 2023-12-29 22:57 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Vallon Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-vallon-pharmaceuticals-inc-5159760) - 2023-12-21 22:13 UTC [SEC Form S-1] [SEC Form S-1 filed by Vallon Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-1-filed-by-vallon-pharmaceuticals-inc-5151761) - 2023-12-20 22:12 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Vallon Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-vallon-pharmaceuticals-inc-5149508) - 2023-12-18 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Vallon Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-vallon-pharmaceuticals-inc-5141809) - 2023-12-15 22:02 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Vallon Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-vallon-pharmaceuticals-inc-5141182) - 2023-12-05 14:07 UTC [SEC Form 8-K] [Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/vallon-pharmaceuticals-inc-filed-sec-form-8-k-other-events-financial-5118657) - 2023-12-04 21:24 UTC [SEC Form S-1] [SEC Form S-1/A filed by Vallon Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-s-1a-filed-by-vallon-pharmaceuticals-inc-amendment-5116815) - 2023-11-27 13:38 UTC [SEC Form 8-K] [Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/vallon-pharmaceuticals-inc-filed-sec-form-8-k-other-events-financial-5103645) - 2023-11-24 21:04 UTC [SEC Form 8-K] [Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/vallon-pharmaceuticals-inc-filed-sec-form-8-k-notice-of-delisting-5102814) - 2023-11-15 13:07 UTC [SEC Form 8-K] [Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/vallon-pharmaceuticals-inc-filed-sec-form-8-k-results-of-operations-5086323) - 2023-11-01 12:45 UTC [SEC Form 8-K] [Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure](https://www.quantisnow.com/insight/vallon-pharmaceuticals-inc-filed-sec-form-8-k-regulation-fd-disclosure-5049218) - 2023-10-13 20:40 UTC [SEC Form S-3] [SEC Form S-3 filed by Vallon Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-vallon-pharmaceuticals-inc-5019879) - 2023-09-26 20:08 UTC [SEC Form 4] [SEC Form 4 filed by Kelly Leanne](https://www.quantisnow.com/insight/sec-form-4-filed-by-kelly-leanne-4988535) - 2023-08-25 20:42 UTC [SEC Form 8-K] [Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/vallon-pharmaceuticals-inc-filed-sec-form-8-k-regulation-fd-disclosure-4939219) - 2023-08-23 13:07 UTC [SEC Form 8-K] [Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/vallon-pharmaceuticals-inc-filed-sec-form-8-k-entry-into-a-4931787) - 2023-08-14 20:10 UTC [SEC Form 4] [SEC Form 4 filed by Szekeres David Leslie](https://www.quantisnow.com/insight/sec-form-4-filed-by-szekeres-david-leslie-4894130) - 2023-08-14 20:07 UTC [SEC Form 4] [SEC Form 4 filed by Simpson Camilla V](https://www.quantisnow.com/insight/sec-form-4-filed-by-simpson-camilla-v-4893949) - 2023-08-14 20:07 UTC [SEC Form 4] [SEC Form 4 filed by Rongen Roelof](https://www.quantisnow.com/insight/sec-form-4-filed-by-rongen-roelof-4893932) - 2023-08-14 20:06 UTC [SEC Form 4] [SEC Form 4 filed by Baker David Charles](https://www.quantisnow.com/insight/sec-form-4-filed-by-baker-david-charles-4893846) - 2023-08-14 12:08 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Vallon Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-vallon-pharmaceuticals-inc-4888797) - 2023-08-14 12:06 UTC [SEC Form 8-K] [Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/vallon-pharmaceuticals-inc-filed-sec-form-8-k-results-of-operations-4888785) - 2023-07-07 20:03 UTC [SEC Form 8-K] [Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/vallon-pharmaceuticals-inc-filed-sec-form-8-k-submission-of-matters-4731612) - 2023-07-06 20:28 UTC [SEC Form 8-K] [Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Financial Statements and Exhibits (Amendment)](https://www.quantisnow.com/insight/vallon-pharmaceuticals-inc-filed-sec-form-8-k-financial-statements-and-4727799) - 2023-06-08 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Vallon Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-vallon-pharmaceuticals-inc-4617316) - 2023-06-07 20:18 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Vallon Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-vallon-pharmaceuticals-inc-4615553) - 2023-05-30 21:01 UTC [SEC Form S-3] [SEC Form S-3 filed by Vallon Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-vallon-pharmaceuticals-inc-4578101) ## More - Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/VLON - Earnings history: https://www.quantisnow.com/earnings/VLON - Dividend history: https://www.quantisnow.com/dividends/VLON - Insider transactions: https://www.quantisnow.com/insiders/VLON - Options chain: https://www.quantisnow.com/options/VLON - SEC 8-K filings only: https://www.quantisnow.com/company/VLON/8-k - RSS and alerts for VLON: https://www.quantisnow.com/docs/rss-feeds.md